Critical Survey EverQuote (NASDAQ:EVER) Vs. Cardlytics (NASDAQ:CDLX)

EverQuote ( NASDAQ:EVER – Get Free Report ) and Cardlytics ( NASDAQ:CDLX – Get Free Report ) are both small-cap financial companies, but which is the better investment? We’ll compare the two businesses based on the strength of profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

Analyst ratings

This is a breakdown of current recommendations and price targets for EverQuote and Cardlytics, as reported by MarketBeat.

EverQuote currently has a consensus price target of $29.58, indicating a potential upside of 39.08%. Cardlytics has a consensus price target of $7.50, indicating a potential upside of 133.64%. Given Cardlytics’ higher possible upside, analysts plainly believe Cardlytics is more favorable than EverQuote.

return

This table compares EverQuote and Cardlytics’ net margins, return on equity and return on assets.

Earnings and Rating

This table compares EverQuote and Cardlytics’ gross revenue, earnings per share and valuation.

EverQuote has higher revenue and earnings than Cardlytics. EverQuote is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Institutional and privileged ownership

91.5% of EverQuote shares are owned by institutional investors. Comparatively, 68.1% of Cardlytics shares are held by institutional investors. 29.8% of EverQuote shares are owned by company insiders. Comparatively, 4.4% of Cardlytics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, big money managers and endowments believe a company will outperform the market over the long term.

Volatility and risk

EverQuote has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Cardlytics has a beta of 1.68, indicating that its share price is 68% more volatile than the S&P 500.

Summary

EverQuote beats Cardlytics in 10 of the 14 factors compared between the two stocks.

About EverQuote

(Get a free report)

EverQuote, Inc. operates an online marketplace for shopping insurance in the United States. The company offers auto, home and renters insurance, and life insurance. The company serves carriers and agents as well as indirect distributors. The company was formerly known as AdHarmonics, Inc. and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

About Cardlytics

(Get a free report)

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. Offers the Cardlytics platform, a proprietary native banking advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels such as online, mobile apps, email and various real-time notifications; and the Bridg platform, a customer data platform that uses point-of-sale data and enables marketers to conduct analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Get EverQuote news and reviews daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for EverQuote and related companies with MarketBeat.com’s FREE daily email newsletter.